Back to search results

PILI Pasifika Program for Cardiometabolic Conditions in Native Hawaiians and Pacific Islanders

This study is testing a 3-month lifestyle program called the PILI Pasifika Program (PPP) to see how well it works and how it can be put into practice in real-world settings. The PPP is designed for Native Hawaiians and Pacific Islanders and focuses on weight loss, healthy eating, and physical activity, while also addressing challenges like access to healthy foods or housing. You may be able to join if you are 18 or older, identify as Native Hawaiian or Pacific Islander, and have conditions like overweight/obesity, pre-diabetes, diabetes, high blood pressure, or high cholesterol. Researchers will measure your Hemoglobin A1C (a measure of blood sugar), lipid panel (cholesterol levels), and blood pressure to see if the program is successful. The study aims to enroll 400 participants, but its current recruitment status is unclear.

Study design
This is an interventional study involving 400 Native Hawaiian and Pacific Islander participants. It is a Type 3 hybrid effectiveness-implementation trial, meaning it evaluates both the program's effectiveness and how well it can be implemented.
What's involved
You would participate in a 3-month behavioral lifestyle intervention. Your Hemoglobin A1C, lipid panel, and blood pressure will be measured at the beginning of the study, after 3 months, and again after 9 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 9 months after the start of the program, with assessments at 3 and 9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07387393

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

Enrolling by Invitation
NAAges 18+InterventionalTreatment
University of Hawaii
~400 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hemoglobin A1C
Measured over Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.
+4 more outcomes measured

Conditions

Cardiometabolic Conditions
Hypertension (HTN)
Dyslipidemia
Pre-diabetes
Type 2 Diabetes Mellitus (T2DM)
Overweight (BMI > 25)
Weight Loss Trial

Explore related trials

DyslipidemiaHypertensionOverweightPrediabetesType 2 Diabetes Mellitus

Where it's being run

2 sites across 2 states
Arkansas1
Hawaii1

Study leadership

  • Joseph K Kaholokula, PhD · PRINCIPAL_INVESTIGATOR · University of Hawaii, Department of Native Hawaiian Health
  • Nia Aitaoto, PhD · PRINCIPAL_INVESTIGATOR · National Association of Pasifika Organizations
  • Sheri-Ann Daniels, EdD · PRINCIPAL_INVESTIGATOR · Papa Ola Lokahi

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Self-identify as Native Hawaiian or Pacific Islander
18 years of age or older
Have at least one of the following self-reported cardiometabolic conditions (Overweight or obesity defined as BMI ≥ 25, pre-diabetes or diabetes, high blood pressure, and/or high cholesterol)
Able to do a moderate level of physical activity or exercise

Exclusion

Do not identify as Native Hawaiian or Pacific Islander
Under 18 years of age
Currently a student
Do not have any of the following conditions (overweight/obesity, pre-diabetes/diabetes, high blood pressure, or high cholesterol)
Have special dietary needs/dietary restrictions (due to cultural reasons and/or told by a healthcare provider)
Pregnant women
Have physical activity limitations/restrictions (told by a healthcare provider)

What this trial measures

  • Hemoglobin A1CAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

    A finger stick sample will be collected to measure hemoglobin A1C using the A1CNow+ kit.

  • Lipid PanelAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

    A fingerstick sample will be collected to measure Total Cholesterol, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), and Triglycerides using the CardioChek Plus Analyzer.

  • Blood PressureAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

    Systolic and diastolic blood pressure will both be measured by a digital blood pressure monitor device (Omron HEM-907XL IntelliSense).

  • WeightAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

    Weight will be calculated using a standardized mobile medical flat scale (Seca 876).

  • Body Mass Index (BMI)Assessment data will be collected at baseline and 3-month follow-up.

    Height data will be measured at baseline using a standardized portable stadiometer. Weight will be measured using a standardized mobile medical flat scale. BMI will be calculated.